Selecting a site will automatically redirect you to the site's homepage.
Researchers have discovered how to “turn off” a key driver of aortic stenosis – the narrowing of the heart’s aortic valve – identifying for the first time the biological process behind certain instances of the disease.
C’Dots, silica-encased nanoparticles developed in the lab of engineering professor Ulrich Wiesner, have just begun their first therapeutic human clinical trial. They’re being further developed by Elucida Oncology Inc., a company co-founded by Wiesner.
A single-cell transcriptomic dataset of mouse skeletal muscle established by Cornell Engineers has become a powerful tool for biological discovery.
Cornell researchers used machine learning to predict with near-perfect accuracy how genes are transferred between bacteria, an approach that could potentially be used to stop the spread of antibiotic resistance.
While some returning students left behind long days at the beach and summer barbeques, the student entrepreneurs in the 2021 cohort of the Kessler Fellows program returned having completed 10-week internships with startups around the nation.
Cornell is one of only seven institutions across the U.S. that will receive a funding award from the National Institutes of Health through a program aimed at increasing minority faculty in the biomedical sciences.
Van der Meulen Lab postdoc Sophia Ziemian receives Achievement Award for Excellence in Mentoring as part of Cornell’s celebration of National Postdoc Appreciation Week, celebrated Sept. 20-24.
